Institutional investors purchased a net $1.5 million shares of SRPT during the quarter ended March 2018, and now own 88.46% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 3.2 Million shares of Sarepta Therapeutics Inc
T. ROWE PRICE ASSOCIATES, INC. Bought 1.5 Million shares of Sarepta Therapeutics Inc